Linda H. Louie's most recent trade in AMGEN Inc. was a trade of 16 Common Stock done at an average price of $231.9 . Disclosure was reported to the exchange on May 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.88 per share. | 05 May 2023 | 16 | 9,966 (0%) | 0% | 231.9 | 3,710 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 3,583 | 3,583 | - | - | Nqso (Right to Buy) | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 423 | 10,002 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.95 per share. | 02 May 2023 | 20 | 9,982 (0%) | 0% | 236.0 | 4,719 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.74 per share. | 30 Apr 2023 | 27 | 9,579 (0%) | 0% | 239.7 | 6,473 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.57 per share. | 17 Mar 2023 | 96 | 9,606 (0%) | 0% | 234.6 | 22,519 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 387 | 9,679 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 269.04 per share. | 05 Nov 2022 | 45 | 9,278 (0%) | 0% | 269.0 | 12,107 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.06 per share. | 02 Nov 2022 | 125 | 9,323 (0%) | 0% | 272.1 | 34,008 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.13 per share. | 05 May 2022 | 15 | 9,404 (0%) | 0% | 236.1 | 3,542 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 3,535 | 3,535 | - | - | Nqso (Right to Buy) | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 433 | 9,437 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.94 per share. | 02 May 2022 | 18 | 9,419 (0%) | 0% | 230.9 | 4,157 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.88 per share. | 27 Apr 2022 | 17 | 9,004 (0%) | 0% | 249.9 | 4,248 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 235.86 per share. | 18 Mar 2022 | 108 | 9,021 (0%) | 0% | 235.9 | 25,473 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 436 | 9,104 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 2,608 | 2,608 | - | - | Nqso (Right to Buy) | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 300 | 8,301 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.67 per share. | 30 Apr 2021 | 18 | 8,283 (0%) | 0% | 239.7 | 4,314 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 239.65 per share. | 30 Apr 2021 | 17 | 8,266 (0%) | 0% | 239.6 | 4,074 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.50 per share. | 27 Apr 2021 | 16 | 8,001 (0%) | 0% | 255.5 | 4,088 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.42 per share. | 19 Mar 2021 | 115 | 8,017 (0%) | 0% | 244.4 | 28,108 | Common Stock |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 467 | 8,113 (0%) | 0% | 0 | Common Stock | |
| Amgen | Linda H. Louie | VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 1,453 | 7,632 (0%) | 0% | 0 | Common Stock |